Beach Point Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Beach Point Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-522,898	Closed	-$7.73M	–	23
2017 Q1	$7.73M	Buy	522,898 +309,354	+145%	+$5.01M	2.18%	12
2016 Q4	$3.46M	Sell	213,544 -949,207	-82%	-$17.2M	1.56%	11
2016 Q3	$21.1M	Sell	1,162,751 -797,398	-41%	-$15.6M	11.27%	4
2016 Q2	$32.3M	Sell	1,960,149 -153,536	-7%	-$2.48M	17.43%	2
2016 Q1	$31.1M	Buy	+2,113,685	New	+$37M	14.01%	2
2015 Q4	–	Sell	-184,700	Closed	-$3.66M	–	24
2015 Q3	$3.66M	Sell	184,700 -609,590	-77%	-$19.3M	0.99%	19
2015 Q2	$27.6M	Sell	794,290 -324,228	-29%	-$9.89M	5.42%	6
2015 Q1	$29M	Buy	+1,118,518	New	+$20.5M	5.3%	6
2013 Q4	–	Sell	-1,881,578	Closed	-$6.3M	–	22
2013 Q3	$6.3M	Buy	1,881,578 +1,360,746	+261%	+$3.59M	1.91%	15
2013 Q2	$1.28M	Buy	+520,832	New	+$1.25M	0.48%	16

Other funds holding HZNP

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Beach Point Capital Management's HZNP Position: Q2 2017 in Review

Beach Point Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2017, closing a stake of 522,898 shares — an estimated $7.73M sold.

Beach Point Capital Management first reported a position in HZNP in Q2 2013 and held it in 10 quarters. The position peaked at $32.3M in Q2 2016. 190 funds tracked by Wall St. Rank hold HZNP as of Q2 2017.

Beach Point Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2017 after selling out during the quarter.
Beach Point Capital Management sold 522,898 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2017, an estimated $7.73M.
Beach Point Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 10 quarters.
Beach Point Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $32.3M in Q2 2016.
190 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2017.

Based on Beach Point Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.